Inventor

JACKSON PAUL F

US51 patents

⚠️ This page may combine multiple inventors who share the name “JACKSON PAUL F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JACKSON PAUL F

GUILFORD PHARM INC

PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same

Naaladase inhibitors

Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage

Prodrugs of NAALAdase inhibitors

Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity

Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity

Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors

Hydroxamic acid derivatives

Certain sulfoxide and sulfone derivatives

Phosphoramidate derivatives

Inhibitors of NAALADase enzyme activity

Certain phosphonomethyl-pentanedioic acid derivatives thereof

Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity

Thio-substituted pentanedioic acid derivatives

Phosphinic alkanoic acid derivatives

Phosphonic acid derivatives

NAALADase inhibitors

Certain dioic acid derivatives useful as NAALADase inhibitors

Methods of cancer treatment using naaladase inhibitors

Treatment of global and focal ischemia using naaladase inhibitors

Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors

Naaladase inhibitors

Treatment of global and focal ischemia using naaladase inhibitors

Methods of cancer treatment using naaladase inhibitors

NAALADase inhibitors

Benzenedicarboxylic acid derivatives

Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors

Methods of cancer treatment using NAALADase inhibitors

Pyrrolecarbonylimino derivatives as naaladase inhibitors

Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same

Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors

Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage

Phosphonic acid derivatives

Hydroxamic acid derivatives

Inhibitors of NAALADase enzyme activity

Treatment of global and focal ischemia using NAALADase inhibitors

NAALADase inhibitors useful as pharmaceutical compounds and compositions

Phosphinic acid derivatives

Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives

Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity

Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives

Substituted ethyl α,α-diarylmethyl ether derivatives

Pyrrolidine derivatives

Benzenedicarboxylic acid derivatives

ZENECA LTD

Substituted nitrogen heterocycles

1-bolizazepin-2,5-diones

LEONARD KRISTI A

Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor

Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases

ORTHO MUNIEL PHARMACEUTICAL IN

Arylindenopyridines and related therapeutic and prophylactic methods

JANSSEN PHARMACEUTICA NV

Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists